Show simple item record

dc.contributor.authorSanderson, R.
dc.contributor.authorKuhnl, A.
dc.contributor.authorTholouli, E.
dc.contributor.authorMenne, T. F.
dc.contributor.authorPatel, Amit
dc.contributor.authorChaganti, S.
dc.contributor.authorBesley, C.
dc.contributor.authorNicholson, E.
dc.contributor.authorLatif, A. L.
dc.contributor.authorJones, C.
dc.contributor.authorRubio, L.
dc.contributor.authorStenson, C.
dc.contributor.authorMathew, A.
dc.contributor.authorSharplin, K.
dc.contributor.authorBazin, J.
dc.contributor.authorNeill, L.
dc.contributor.authorCheok, K. P. L.
dc.contributor.authorJalowiec, K. A. A.
dc.contributor.authorRoddie, C.
dc.contributor.authorO'Reilly, M. A.
dc.date.accessioned2022-10-19T13:13:17Z
dc.date.available2022-10-19T13:13:17Z
dc.date.issued2021en
dc.identifier.citationSanderson R, Kuhnl A, Tholouli E, Menne TF, Patel A, Chaganti S, et al. CAR-T Toxicity Management and Steroid Use in High-Grade BCell Lymphoma: Impact on Real-World Survival Outcomes in the UK. Blood. 2021 Nov;138. PubMed PMID: WOS:000736398802073.en
dc.identifier.doi10.1182/blood-2021-149501en
dc.identifier.urihttp://hdl.handle.net/10541/625632
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1182/blood-2021-149501en
dc.titleCAR-T toxicity management and steroid use in high-grade BCell lymphoma: impact on real-world survival outcomes in the UKen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentKing's College Hospital, London, United Kingdomen
dc.identifier.journalBlooden
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record